Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice

Abstract

Macrophage polarization and inflammation are key factors for the onset and progression of atherosclerosis. The immunoproteasome complex consists of three inducible catalytic subunits (LMP2, LMP10, and LMP7) that play a critical role in the regulation of these risk factors. We recently demonstrated that the LMP7 subunit promotes dietinduced atherosclerosis via inhibition of MERTK-mediated efferocytosis. Here, we explored the role of another subunit of LMP10 in the disease process, using ApoE knockout (ko) mice fed on an atherogenic diet (ATD) containing 0.5% cholesterol and 20% fat for 8 weeks as an in vivo atherosclerosis model. We observed that ATD significantly upregulated LMP10 expression in aortic lesions, which were primarily colocalized with plaque macrophages. Conversely, deletion of LMP10 markedly attenuated atherosclerotic lesion area, CD68 + macrophage accumulation, and necrotic core expansion in the plaques, but did not change plasma metabolic parameters, lesional SM22α + smooth muscle cells, or collagen content. Myeloid-specific deletion of LMP10 by bone marrow transplantation resulted in similar phenotypes. Furthermore, deletion of LMP10 remarkably reduced aortic macrophage infiltration and increased M2/M1 ratio, accompanied by decreased expression of pro-inflammatory M1 cytokines (MCP-1, IL-1, and IL-6) and increased expression of anti-inflammatory M2 cytokines (IL-4 and IL-10). In addition, we confirmed in cultured macrophages that LMP10 deletion blunted macrophage polarization and inflammation during ox-LDL-induced foam cell formation in vitro, which was associated with decreased IκBα degradation and NF-κB activation. Our results show that the immunoproteasome subunit LMP10 promoted diet-induced atherosclerosis in ApoE ko mice possibly through regulation of NF-κBmediated macrophage polarization and inflammation. Targeting LMP10 may represent a new therapeutic approach for atherosclerosis.

KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages

“…The roles of IL-6 in macrophages polarization are complex and various. In some particular conditions, IL-6 was regarded as pro-inflammatory M1 signature marker [56][57][58]. However, in other conditions IL-6 was expressed by M2 macrophages, such as the increased production of IL-6 by M2 macrophages which were induced by heparanase enzyme highly expressed pancreatic carcinoma cells [59].…”

ZBTB20 Positively Regulates Oxidative Stress, Mitochondrial Fission, and Inflammatory Responses of ox-LDL-Induced Macrophages in Atherosclerosis

“…Macrophages can be divided into M1 or M2 type, depending on the polarization state, all of which were derived from monocytes [50]. Recent studies showed that M2 macrophages could clear dying cells and debris and secrete antiinflammatory factors, which can attenuate the formation of AS plaques [51]. Our results showed that the ZBTB20 knockdown increased the M2 macrophage polarization but decreased the M1 macrophage polarization, implying that the ZBTB20 knockdown may attenuate AS by activating M2 macrophages.…”

HOXA5 induces M2 macrophage polarization to attenuate carotid atherosclerosis by activating MED1

“…Previous studies have demonstrated the important role of macrophage polarization toward an M1/M2 subtype in atherosclerosis. For example, it was shown that LMP10 ablation inhibited macrophage polarization toward the proinflammatory M1 subtype 26 . HOXA5 was reported to promote adipose macrophages switching toward M2 phenotypes and attenuate chronic inflammation 19,20 .…”